2022 Çѱ¹Á¤½Å½ÅüÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2022-06-24±³À°ÀÏÀÚ : 2022-06-24
±³À°Àå¼Ò : ¹Ð·¹´Ï¿òÈúÆ°¼¿ï ±×·£µåº¼·ë A,B·ë
±³À°ÁÖÁ¦ :
2022 Çѱ¹Á¤½Å½ÅüÀÇÇÐȸ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : Çѱ¹Á¤½Å½ÅüÀÇÇÐȸ
´ã´çÀÚ : ±èÁø¿Á
¿¬¶ôó : 070-4888-5731
À̸ÞÀÏ :
sericonf@hanmail.net ±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 13 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í Àü¹®ÀÇ-80,000, Àü°øÀÇ-50,000, Æò»ýȸ¿ø-¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-24 A·ë 09:10~09:25 ÇãÇ÷¼º ½ÉÁúȯ¿¡¼ ½É¸®Àû µð½ºÆ®·¹½º¿¡ µû¸¥ ÀÓ»ó ¾ç»óÀÇ Â÷ÀÌ ±èż®(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06-24 A·ë 09:25~09:40 º¥Á¶µð¾ÆÁ¦ÇÉ Áß´Ü ¸Þ´º¾ó °µîÇö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-24 A·ë 09:40~09:55 ¿ì¿ïÁõ û¼Ò³â¿¡¼ÀÇ ÀÏÁֱ⠸®µë º¯È À̹®¼ö(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06-24 A·ë 09:55~10:10 ±âÁ¸ ±Ù°ÅÀÇ Ã¼°èÀû °ËÅä ¹× ÇÕ¼ºÀ» ÅëÇÑ ¡®Ç×Á¤½Åº´¾à¹° À¯µµ¼º °íÇÁ·Ñ¶ôƾÇ÷Áõ¡¯ÀÇ ÀÓ»óÁø·áÁöħ °³¹ß ±è¼±¹Ì(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 06-24 A·ë 10:10~10:25 ¿Ü»óÈÄ ½ºÆ®·¹½º ȯÀÚÀÇ ½ÅüÁõ»ó ÁõÆø Á¤µµ¿Í ÀÎÁöÁ¤¼Á¶Àý Àü·« ±ÇÁÖÇÑ(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 06-24 A·ë 10:25~10:40 ¼Ò¾Æû¼Ò³â ¿ì¿ïÁõ¿¡¼ µ¿¹ÝµÈ ±â´É¼º À§ÀåÁúȯ ¾çÂù¸ð(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 06-24 A·ë 10:50~11:15 Special population: LGBTQ+ À±Çö¹è(¼¿ï´ë ÀÇÇб³À°½Ç)
±³À°½Ã°£ 06-24 A·ë 11:15~11:40 Epidemiology of psychiatric disorder in LGBTQ+ & Beyond ÀåâÇö(»ì¸²ÀÇ¿ø)
±³À°½Ã°£ 06-24 A·ë 11:40~12:05 ¼ºº° ºÒÄè°¨¿¡¼ÀÇ È£¸£¸ó Ä¡·á ¹× LGBT people°úÀÇ ¸é´ã ÃÖÀα¤(ÃÖÀα¤Á¤½Å°Ç°ÀÇÇаú)
Åä·Ð 06-24 A·ë 12:05~12:20 Q & A ()
±³À°½Ã°£ 06-24 A·ë 12:20~12:50 Optimizing treatment for patients with MDD: The advantage of 20mg dose of Vortioxetine È«Á¤¿Ï(Àͻ꺴¿ø)
±³À°½Ã°£ 06-24 A·ë 12:50~13:20 Emotional blunting and Anhedonia management with Vortioxetine ±è¼±¹Ì(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 06-24 A·ë 14:00~14:30 Comparison of depression and delirium with Alzheimer¡¯s Disease using cognitive function tests Dr. Taro Fukue(Yokohama National University)
±³À°½Ã°£ 06-24 A·ë 14:30~15:00 Development and Clinical Use of a Dietary Management App for Eating Disorders in Japan Dr. Tsuneo Yamauchi(Osaka Metopolitan University)
±³À°½Ã°£ 06-24 A·ë 15:00~15:25 ¼Ò¾Æ ÀÌÁ¾ÇÏ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06-24 A·ë 15:25~15:50 ¼ºÀαâ Àå½ÂÈ£(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 06-24 A·ë 15:50~16:15 ³ëÀÎ (Ä¡¸Å±¹°¡Ã¥ÀÓÁ¦) ¾çÇöÁÖ(Á¦ÁÖÀÇ´ë)
Åä·Ð 06-24 A·ë 16:15~16:30 Q & A ()
±³À°½Ã°£ 06-24 B·ë 09:10~09:35 ±Í ¿¬°ü ¾îÁö·³Áõ ȯÀÚ Áø´Ü°ú Ä¡·á ¼¸íȯ(¼¿ïÀÇ´ë À̺ñÀÎÈÄ°ú)
±³À°½Ã°£ 06-24 B·ë 09:35~10:00 ³úÇ÷°üÁúȯ/ÅðÇ༺³úÁúȯ ¿¬°ü ¾îÁö·³Áõ ȯÀÚ Áø´Ü°ú Ä¡·á À̼±¿í(°í·ÁÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 06-24 B·ë 10:00~10:25 Á¤½Å½ÅüÀå¾Ö Áõ»óÀ¸·Î¼ÀÇ ¾îÁö·³Áõ ȯÀÚ Áø´Ü°ú Ä¡·á ¹ÚÇý¿¬(¼¿ïÀÇ´ë)
Åä·Ð 06-24 B·ë 10:25~10:40 Q & A ()
±³À°½Ã°£ 06-24 B·ë 10:50~11:15 ´ç´¢¿¡¼ÀÇ digital therapeutics ·ùÇýÁø(°í´ë±¸·Î ³»ºÐºñ³»°ú)
±³À°½Ã°£ 06-24 B·ë 11:15~11:40 ¸¸¼ºÅëÁõ Ä¡·á¿ë ½Å°æÀÚ±âÀÚ±Ø(NMS) Àåºñ ¹Î°æÈÆ(ºÐ´çÂ÷º´¿ø ÀçÈ°ÀÇÇаú)
±³À°½Ã°£ 06-24 B·ë 11:40~12:05 ¸¶À½Ã¬±è¸í»ó À¯Á¤Àº(¸¶º¸)
Åä·Ð 06-24 B·ë 12:05~12:20 Q & A ()
±³À°½Ã°£ 06-24 B·ë 12:20~12:50 A Paradigm Shift to Recover from Depression À̹®¼ö(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06-24 B·ë 12:50~13:20 Therapeutic Advantage of Agomelatine in Treating Depression °¿ø¼·(°æÈñÀÇ´ë)
±³À°½Ã°£ 06-24 B·ë 14:00~14:25 ºñ¸¸ ¹× ´ë»çÁúȯÀÇ ÀÌÇØ ¾ç¿¹½½(°¡Å縯ÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 06-24 B·ë 14:25~14:50 ºñ¸¸ÀÇ ¾à¹°ÇÐÀû Ä¡·á ¼ºÇü¸ð(¼øõÇâÀÇ´ë)
Åä·Ð 06-24 B·ë 14:50~15:00 Q & A ()
±³À°½Ã°£ 06-24 B·ë 15:00~15:25 Á¤½Å½ÅüÀÇÇÐÀÇ ±³À° ¿ÀÈ«¼®(°Ç¾çÀÇ´ë)
±³À°½Ã°£ 06-24 B·ë 15:25~15:50 Á¤½Å½ÅüÀÇÇÐ ºÐ¾ß¿¡¼ÀÇ ¿¬±¸ È°¼ºÈ ¹æ¾È ÇÔºÀÁø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-24 B·ë 15:50~16:15 Á¤½Å½ÅüÀÇÇÐÀû ÀÚ¹®¿¡¼ÀÇ ÀûÁ¤ ¼ö°¡¶õ À̺´Ã¶(ÇѸ²ÀÇ´ë)
Åä·Ð 06-24 B·ë 16:15~16:30 Q & A ()